Diane Jorkasky Net Worth

The estimated Net Worth of Diane Jorkasky is at least $126 Mille dollars as of 27 June 2022. Diane Jorkasky owns over 17,610 units of Altimmune Inc stock worth over $126,264 and over the last 5 years he sold ALT stock worth over $0. In addition, he makes $0 as Director at Altimmune Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Diane Jorkasky ALT stock SEC Form 4 insiders trading

Diane has made over 1 trades of the Altimmune Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently he exercised 17,610 units of ALT stock worth $55,472 on 27 June 2022.

The largest trade he's ever made was exercising 17,610 units of Altimmune Inc stock on 27 June 2022 worth over $55,472. On average, Diane trades about 2,935 units every 0 days since 2020. As of 27 June 2022 he still owns at least 17,610 units of Altimmune Inc stock.

You can see the complete history of Diane Jorkasky stock trades at the bottom of the page.

Diane Jorkasky biography

Dr. Diane K. Jorkasky M.D. serves as Director of the Company. She has served on the board of directors of Alzheon, Inc., a private biopharmaceutical company, since December 2019 and also served on the board of directors of Q Therapeutics, Inc. from September 2013 until August 2016. From June 2014 to August 2019, she served as Executive Vice President, Chief Medical Officer and Head of Development at Complexa Inc., a clinical stated biopharmaceutical company. Dr. Jorkasky received her MD in 1977 from the University of Pennsylvania School of Medicine and is board certified in internal medicine, nephrology and clinical pharmacology. She is a member of the Connecticut Academy of Science and Technology. Dr. Jorkasky is on the faculties of University of California, San Francisco, and Uniformed Service of Health Sciences Medical Schools, with previous faculty appointments at Yale University and the University of Pennsylvania Schools of Medicine.

How old is Diane Jorkasky?

Diane Jorkasky is 68, he's been the Director of Altimmune Inc since 2020. There are 3 older and 9 younger executives at Altimmune Inc. The oldest executive at Altimmune Inc is David Drutz, 81, who is the Independent Director.

What's Diane Jorkasky's mailing address?

Diane's mailing address filed with the SEC is C/O ALTIMMUNE, INC.,, 910 CLOPPER ROAD, SUITE 201S, GAITHERSBURG, MD, 20878.

Insiders trading at Altimmune Inc

Over the last 7 years, insiders at Altimmune Inc have traded over $2,557,810 worth of Altimmune Inc stock and bought 3,362,060 units worth $23,898,779 . The most active insiders traders include Bioventures Ltd Novartis Ag..., Healthcare Capital Partners... e Mitchel Sayare. On average, Altimmune Inc executives and independent directors trade stock every 35 days with the average trade being worth of $432,889. The most recent stock trade was executed by David Drutz on 19 August 2024, trading 41,750 units of ALT stock currently worth $106,463.

What does Altimmune Inc do?

altimmune, inc. is a clinical stage biotechnology company developing next-generation immunotherapeutics and vaccines to address significant public health and biodefense needs. by leveraging specific attributes of its two independent and complementary platform technologies, altimmune can rapidly design product candidates against a wide range of disease targets, including respiratory diseases, chronic infections, and cancer. our densigen™ t-cell platform technology is uniquely suited to direct the immune response against traditionally difficult disease targets, including chronic infections and cancer, by directing an individual’s immune system against multiple target antigens instead of just one. altimmune’s respirvec™ platform utilizes convenient needle-free intranasal delivery to achieve broad immunity against disease pathogens more rapidly than conventional vaccines. vaxin’s product candidates are easily manufactured, highly stable, and provide a safe, effective alternative to current

Complete history of Diane Jorkasky stock trades at Altimmune Inc

Altimmune Inc executives and stock owners

Altimmune Inc executives and other stock owners filed with the SEC include:

• Dr. Vipin K. Garg Ph.D.,
  Pres, CEO & Director
• William Brown,
  Chief Financial Officer, Principal Accounting Officer
• Dr. Matthew Scott Harris M.D., MS, FCAP, AGAF,
  Chief Medical Officer
• Vipin Garg,
  President, Chief Executive Officer, Director
• Dr. M. Scot Roberts,
  Chief Scientific Officer
• John Gill,
  Independent Director
• M. Scott Harris,
  Chief Medical Officer
• Mitchel Sayare,
  Chairman of the Board
• Ashley Robinson,
  IR Contact Officer
• Klaus Schafer,
  Independent Director
• Wayne Pisano,
  Independent Director
• Philip Hodges,
  Independent Director
• David Drutz,
  Independent Director
• Diane Jorkasky,
  Director
• M. Scot Roberts,
  Chief Scientific Officer
• José Ochoa,
  Chief Bus. Officer
• Bertrand Georges Ph.D.,
  Chief Technology Officer
• Richard I. Eisenstadt M.B.A.,
  CFO and Principal Financial & Accounting Officer
• Sybil Tasker,
  Chief Medical Officer
• Philip Hodges,
  Director
• Derace L Schaffer,
  Director
• Capital S.A.S. Truffle,
  10% owner
• Bioventures Ltd Novartis Ag...,
  
• William Enright,
  President and CEO
• Elizabeth Czerepak,
  CFO and EVP Corp. Development
• Healthcare Capital Partners...,
  
• Pharmaceutical Holdings Llc...,
  10% owner
• Richard I Eisenstadt,
  Chief Financial Officer
• Raymond M Jordt,
  Chief Business Officer
• Catherine A. Sohn,
  Director
• Andrew Shutterly,
  Acting Chief Financial Officer